Dosing has begun in a global clinical trial testing Revolution Medicines‘ RAS(ON) inhibitor candidate zoldonrasib as a first-line treatment for advanced pancreatic ductal carcinoma…

Some mornings the mirror catches me off guard. I know this might sound strange, especially when one is new to caregiving. But I haven’t just…

Starting the electrical therapy Optune Gio during radiation therapy and chemotherapy, rather than after it as indicated, did not extend survival in people with newly…